Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors

Zhao W.; Dong L.; Wang H.; Zheng X.; Zhang C.; Wang K.; Zhu G.; Wang B.; Qin M.; Liu Y.; Zhang D.; Jin M.; Zheng H.; Zhang L.; Ma X.

首页> 外文期刊>Pediatric blood & cancer >Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors

【24h】

Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors

机译：难治性和复发性小儿实体瘤中的嵌合抗原受体4SCAR-GD2 / CD56修饰的T细胞

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2016年第3期|共1页
作者
Zhao W.; Dong L.; Wang H.; Zheng X.; Zhang C.; Wang K.; Zhu G.; Wang B.; Qin M.; Liu Y.; Zhang D.; Jin M.; Zheng H.; Zhang L.; Ma X.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors [J] . Zhao W., Dong L., Wang H., Pediatric blood & cancer . 2016,第Suppla3期

机译：难治性和复发性小儿实体瘤中的嵌合抗原受体4SCAR-GD2 / CD56修饰的T细胞
2. B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models [J] . Luo, Wang, J., Oncoimmunology. . 2020,第1期

机译：B7-H3具有嵌合抗原受体和诱饵PD-1受体的特异性T细胞在小鼠模型中根除已建立的固体人肿瘤
3. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting [J] . Slaney Clare Y., von Scheidt Bianca, Davenport Alexander J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2017,第10期

机译：双特异性嵌合抗原受体T细胞和间接疫苗在免疫活性剂，自抗原设置中消除各种大型实体瘤
4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
5. Optimizing Chimeric Antigen Receptor (CAR) T Cells for an Enhanced and Broadened Anti-Tumor Immune Response Via Il-36γ [D] . Li, Xinghuo. 2020

机译：优化嵌合抗原受体（汽车）T细胞通过IL-36γ进行增强和扩大的抗肿瘤免疫应答
6. IMMU-11. BRAINCHILD PIPELINE: LOCOREGIONAL IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RECURRENT/REFRACTORY CENTRAL NERVOUS SYSTEM TUMORS [O] . Nicholas Vitanza, Juliane Gust, Sarah Leary, 2018

机译：IMMU-11。脑儿童管道：局部或局部嵌合免疫中枢神经系统肿瘤的嵌合抗原受体（CAR）T细胞免疫治疗。
7. IMMU-11. BRAINCHILD PIPELINE: LOCOREGIONAL IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RECURRENT/REFRACTORY CENTRAL NERVOUS SYSTEM TUMORS [O] . Nicholas Vitanza, Juliane Gust, Sarah Leary, 2018

机译：IMMU-11。 Brainchild管道：带有嵌合抗原受体（汽车）T细胞的型型免疫疗法用于复发/难治性中枢神经系统肿瘤

Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors

著录项

相似文献

相关主题

期刊订阅